Cargando…
Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers
BACKGROUND: Claudin-low breast cancer is a molecular subtype associated with poor prognosis and without targeted treatment options. The claudin-low subtype is defined by certain biological characteristics, some of which may be clinically actionable, such as high immunogenicity. In mice, the medroxyp...
Autores principales: | Fougner, Christian, Bergholtz, Helga, Kuiper, Raoul, Norum, Jens Henrik, Sørlie, Therese |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670237/ https://www.ncbi.nlm.nih.gov/pubmed/31366361 http://dx.doi.org/10.1186/s13058-019-1170-8 |
Ejemplares similares
-
Re-definition of claudin-low as a breast cancer phenotype
por: Fougner, Christian, et al.
Publicado: (2020) -
Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors
por: Bergholtz, Helga, et al.
Publicado: (2022) -
Rapid assessment of 3-dimensional intra-tumor heterogeneity through cycling temperature capillary electrophoresis
por: Połeć, Anna, et al.
Publicado: (2023) -
The tankyrase inhibitor G007-LK inhibits small intestine LGR5(+) stem cell proliferation without altering tissue morphology
por: Norum, Jens Henrik, et al.
Publicado: (2018) -
Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)